Cognitive functioning and myofascial pain in temporomandibular disorders by Biegańska-Banaś, Joanna et al.
277
COGNITIVE FUNCTIONING AND MYOFASCIAL PAIN  
IN TEMPOROMANDIBULAR DISORDERS
Joanna Biegańska-Banaś1,2, Ewa Ferendiuk3, Józef Krzysztof Gierowski4, Małgorzata Pihut3
1Chair of Psychiatry, Department of Medical Psychology, Jagiellonian University Medical College, Cracow, Poland
2Chair of Psychology, SWPS University of Social Sciences and Humanities, Warsaw, Poland
3Department of Dental Prosthetics, Jagiellonian University Medical College, Cracow, Poland
4SWPS University of Social Sciences and Humanities, Katowice, Poland
A B S T R A C T
Introduction: Physical examination of patients suffering from temporomandibular disorders is increasingly 
accompanied by monitoring their psychological functioning. It includes basic diagnostics of the emotional and 
motivational sphere as well as, although rarely, the social sphere. Analysis of the pain profile changing under the 
influence of the therapeutic process and including the psychoneurophysiological aspect of the phenomenon sug-
gests the need to extend the scope of assessment. Specific aspects of cognitive functioning covered by the research 
are mental activities that allow to create and modify knowledge about the environment and to control one’s own 
reactions. 
Objectives: The aim of this article is to describe in detail the cognitive functioning of patients suffering from 
temporomandibular disorders at various stages of prosthetic treatment, with particular emphasis on the experi-
ence of chronic pain.
Material and methods: The study included 45 patients, 23 were diagnosed with myofascial pain form of 
temporomandibular disorders and 22 diagnosed with temporomandibular disorders showing the same patho-
mechanism, but not reporting pain. Scheduled analysis included a number of inter-group comparisons based on 
the data obtained by using selected psychological tests and neuropsychological clinical trials.
Results: Statistically significant differences in cognitive functioning of patients suffering from pain due to tem- 
poromandibular disorders and those patients who did not experience pain, although were diagnosed with  
temporomandibular disorders, were observed. 
Conclusions: It is important to take into account the psychological functioning of patients in a broader 
sense,  including the neuropsychological mechanism of temporomandibular disorders myofascial pain. 
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INTRODUCTION
ETYMOLOGY OF “MYOFASCIAL PAIN SYNDROME” TERM
Temporomandibular disorders have been variously 
defined over the  years. Initially known as “Costen syn-
drome”, concerns a group of symptoms including any dis-
turbance of the jaw and ear due to loss of the back teeth 
in the  jawbone and their too strong compression  [1]. 
Later popularization of the name “pain and dysfunction 
syndrome of temporomandibular joint”, “functional dis-
orders of  temporomandibular joint”, “jaws’ compression 
disorders” or “myoarthropathy of  temporomandibular 
joint” was supposed to refer to alleged etiological factors 
connected with clinical symptoms [2-6]. However, due to 
the fact that the symptoms the above-mentioned names 
refer to occur not only in joints and muscles of the mas-
ticatory organ, some authors considered these terms too 
narrow, and further suggestions as for the names appeared 
such as “jaw and skull disorders” [7] or the  (currently 
most popular though not non-universal) term “temporo-
mandibular disorders” [8].
In the  meantime the  authors who wanted to un-
derline that pain constitutes one of the most important 
symptoms of this clinical unit defined it as a “pain syn-
drome of masticatory organ dysfunctions”, “myofascial 
pain syndrome” and “pain syndrome of  temporoman-
dibular joint dysfunctions” [3, 5, 9]. They noted that pain 
was the most essential factor that motivates patients to 
search for specialized help.
“Myofascial pain syndrome” (as understood in this 
article) is a  wider term including movement organ 
disorders, in the etiology of which the priority is mus-
cular component-like symptoms (as opposed to joint 
component) that raise the  pain symptom to the  level 
of the leading one. Myofascial pain syndrome diagnosed 
in this way does not constitute a  separate unit within 
the  International Classification of  Diseases (ICD), be-
longing to category M79.1 (myalgia) [10].
MECHANISM OF MYOFASCIAL PAIN FORMATION
As a result of persistent temporomandibular disorders, 
a  complex dysfunction of nerves and muscles, including 
movement disorders and sensory disorders within the 
central and peripheral nervous systems,  developes [11]. 
In general it is easy to extract a number of changes and 
irregularities concerning interactions between oppo-
site teeth, muscles responsible for articulation move-
ments of  the  jaws and temporomandibular joint, on 
the  basis of  which chronic pain syndrome is shaped. 
If natural muscles functions‘ disorders, appearing as 
a consequence, continue, a number of local (biochemical) 
and global (structural) changes follow. The effect of fixed 
muscle injury, as well as developing further changes in 
muscle tissues that follow the injury, is persistent, perma-
nent pain. If it lasts longer than 3 months, or does not dis-
appear in spite of removing the reason of its occurrence, it 
is possible to diagnose it as chronic pain. Such pain affects 
the central nervous system and further enhances muscle 
and brain reactions. 
Myofascial pain features local discomfort with 
sensitive areas experience associated with over-sensi-
tive groups of muscle tissues called myofascial  trigger 
points [12]. Knowledge about the mechanism of trigger 
points is incomplete, however most often covered with 
the combination of two leading theories: the theory 
of energy crisis and the motor theory of final junction 
[13-15, 17]. Simultaneously, it has been suggested that 
some end zones in muscle tissue can become sensitized 
by algogen – a  substance that signals damage within 
the tissue. In the trigger points area temperature increas-
es, which suggests higher metabolic demand and the ne-
cessity to reduce the blood flow to the problematic mus-
cle tissue. It leads to tissue microvasculature disorders 
and decreased oxygen supply, which further disturbs 
the ability to gather energy (ATP) and metabolites [18] 
and eventually become the source of permanent, deep 
pain through the processes of stimulation and sensitiz-
ing of end zones. Trigger points can also evoke the cen-
tral stimulation effects in peripheral zones when a group 
of  interconnected interneurons is stimulated  [19, 20]. 
Strong interaction of chemical and mechanical reflexes 
enhances sensitization of  peripheral nerve ends and 
autonomic nerve fibers, resulting in reflective pain, in-
crease in excitability of pain receptors as well as general 
hyperalgesia beyond the  initial nociceptive area  [21]. 
Acetylcholine leads to increased muscle tension which, 
eventually, evokes the  energy crisis  [22]. It probably 
originates from the interference during the integration 
mechanisms in the spinal cord, which constitutes a re-
sponse to sensitization of  nerve fibers connected with 
motor plates’ (contact places of muscle tissues and mo-
tor neurons) incorrect functioning [23] or intrafusal 
fibers’ (modified muscle fibers creating muscle spindles) 
irritation [15, 24].
As a  consequence of  the above-described mecha-
nism there is a  functional and structural reorganiza-
tion of the central nervous system [25-27], comprising 
changes in the grey matter in the callosal gyrus, the or-
bital cavity and the forehead cortex, the insula, the dor-
sal part of the pontine, the thalamus, the dorsal and side 
part of  the  prefrontal cortex, the  nucleus and the  hip-
pocampus. Patients suffering from chronic myofascial 
pain present atrophy of  the grey matter in dorsal and 
abdominal prefrontal areas as well as in the  front hip-
pocampus, being regions participating in modulation 
of  pain, processing emotions and behavioral self-regula-
tion as well as imagining and evoking scenes, future, au-
tobiographical memories and visual perception  [28, 29]. 
These morphological as well as behavioral effects of long-
term exposure to chronic pain are often close in their im-
age to long-term effects of interference in the masticatory 
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process. Direct reasons are to be searched for in either 
lower activity of  the parasympathetic nervous system 




Neuropsychology is a science that involves describing 
the  connection between construction and functioning 
of central nervous system as well as behavior. The behav-
ior is perceived with reference to few aspects: cognitive 
functioning (perception, memory, thinking, language 
skills such as reading and writing, constructive functions 
and praxis), executive functioning (that is being in close 
connection with action that is initiative and monitoring 
processes, and the  ones finishing every action), global 
functioning (consisting of  processes revealed in human 
behavior and characterized by great changeability, such 
as attention processes or psychomotor speed) as well as 
personal and emotional sphere  [30]. In  practice all 
the  above, excluding emotional aspect, are investigated 
together under the common name of “cognitive function-
ing”. Cognitive functions can be defined as mental activi-
ties enabling recognition of features and forms of the out-
er and inner environment, consolidating and combining 
them into a common and rather permanent representa-
tion. Therefore, it is an  individual system of knowledge 
about the  world enabling proper reaction to changing 
inner and outer situations or a change in conformity with 
own needs  [31]. Cognitive functions can be divided in 
general into basic and complex ones. The first of them in-
clude perception, attention and memory, whereas the sec-
ond ones include thinking (imagination), language func-
tion, cognitive control and executive functions [32]. 
The most often observed cognitive disorders (that 
is interference of  mental processes) being the  result 
of  chronically experienced pain are decreased efficien-
cy in the  scope of  attention possibilities, psychomotor 
speed and memory as well as solving problems, abstract 
thinking and cognitive effectiveness [33-37]. Information 
devoted to these issues also include research conducted 
on patients with muscle and skeleton system disorders. 
Research devoted to patients with fibro myalgia, rheuma-
toid patients arthritis, experiencing muscle and skeleton 
pain with different placement and chronic pain of back 
demonstrated lowered attention, operation memory and 
memory dysfunctions in the broad sense (considering se-
mantic and episode memory) [38-42].
Apart from the above, neuropsychological profiles can 
be separated for people experiencing chronic pain typi-
cal for a specific dysfunction in which disorder of some 
cognitive functions turns into leading disorder in spite 
of the fact that they do not exclude presence of other cog-
nitive disorders. For example, it is accepted that in the case 
of  fibromyalgia memory disorders (mainly episode and 
semantic memory) are the leading ones, however, it must 
be noted that the  deficiency refers to explicit memo-
ry only while implicit memory remains untouched  [38, 
43-46]. So far, however, the  neuropsychological profile 
for experiencing myofascial pain in the  course of  tem-
poromandibular disorders has not been fully described – 
it seems so far that the main research efforts have been 
focused on the  isolating of emotional factors regulating 
the occurrence and the course of disorders. 
OBJECTIVES
This article tries to empirically establish the pro-
file of cognitive disorders for a clinical group experi-
encing myofascial pain in the course of temporoman-
dibular disorders as compared to a  group of  people 
who do not experience pain despite this type of dis-
orders.
MATERIAL AND METHODS
The study included 45 people aged 20 to 75 
(M = 35.39; SD = 11.03). The treatment group consist-
ed of 23 people aged 20 to 75 (M = 35.63; SD = 12.19), 
14 women and 9 men. The  control group consisted of 
22 people aged 24-53 (M = 35.06; SD = 9.49), 13 women 
and 9 men. The subjects were recruited from the patients 
diagnosed with the painful form of muscle-related tem-
poromandibular disorders, who entered the clinic with 
the  purpose of  diagnosis and specialist treatment for 
the  first time. The  exclusion criteria were the  patients’ 
will and the  general diseases that prevent the  planned 
test procedure. Financial compensation for participation 
in the study was not provided; how ever, the patients had 
the opportunity to attend five psychoeducational meet-
ings with a psychologist aimed at increasing awareness 
of a psychogenic factor in temporomandibular disorders 
and better stress management by learning techniques 
for reducing the  level of  perceived psychophysical 
tension.
Table 1 shows the  frequency distribution of  drugs 
used in the treatment of the subjects from the treatment 
group. Nonsteroidal anti-inflammatory drugs were 
mainly used in the treatment. Only four subjects from 
the treatment group were not treated with these drugs.
The study formed part of  a  bigger research project 
and was conducted with the use of psychological ques-
tionnaires measuring the  currently and/or previously 
experienced pain as well as the quality of life among pa-
tients with temporomandibular disorders, in addition to 
psychological tests of paper-and-pencil type and com-
puter clinical trials, consisting in performing tasks that 
measure specific cognitive functions. 
The test battery consisted of: 
• Demographics – self-made tool, used for gathering 
basic sociodemographic data as well as some of the 
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variables controlled further in the  study: duration 
of pain experience, previous treatment, pharmacolog-
ical background (drugs used, doses, etc.).
• Visual Analogue Scale (VAS) – a  straight 100 mm 
long line with a clearly marked beginning (no pain) 
and its end (unbearable pain). The aim of each ex-
amined person is to mark a point on the scale which 
corresponds to the level of severity of pain.
• Pain Evaluation Sheet (Szatanik) – this is a shortened 
version of  the  McGill-Melzack Pain Questionnaire. 
The  original tool consists of  78 adjectives (descrip-
tors) divided into 3 classes: sensory, affective and eval-
uative. Each examined person chooses descriptors 
which best describe what she currently experiences. 
The version of the tool used in this project is simpli-
fied, consisting of 43 words divided into 2 categories: 
sensory and emotional. Reliability (Cronbach’s α) 
of this questionnaire is acceptable (0.6-0.81).
• Californian Verbal Learning Test (RVLT) – this test 
requires that an  examinee tries to repeat a  list of 16 
words previously read to him. This procedure is re-
peated five times, then the researcher reads a different 
list of 15 words, and each person is asked to repeat it. 
Then the examinee is asked to try to repeat words from 
the first list. 
• Attention and Perception Test (TUS – Test Uwagi 
i Spostrzegawczości) – each examinee is asked to mark 
(during three minutes) some symbols among different 
but similar ones (e.g. numbers ‘3 and 8’ among others. 
Each person will be administered one of  two equal 
versions of the task. 
• Digit Span Task (DST, a subscale in the Wechsler Intelli-
gence Scale) – a person is required to repeat 3-9 digits 
for ward and then 2-9 digits backwards. This subscale 
mea sures working memory, attention and concentration. 
• Color Trail Test (CTT) – this test consists of two parts, 
A and B. It requires immediate recognition of symbolic 
meaning of numbers and letters, as well as an ability to 
repeatedly eye-search the entire worksheet in order to 
find the next number or letter under time pressure. 
• Verbal Fluency Test (VFT) – each person is sup-
posed to generate words beginning with an  indi-
cated letter for a period of 1.5 minutes, and then to 
generate words belonging to a category indicated by 
the researcher for the next 1.5 minutes. 
• Wisconsin Card Sorting Test (WCST) – computer 
version: a  person is presented with 4 sample cards 
and then she must divide up to 128 cards by follow-
ing a certain rule (color, number or shape). This is 
a  tool frequently used for measuring some aspects 
of cognitive control. 
• Go-No go clinical trial – a person is asked to react by 
pushing a button whenever a letter e.g. ‘p’ is present-
ed on the screen and not to react if e.g. ‘r’ is presented 
that way. In the second part of the study the person 
should now react when ‘r’ presented and not react 
when ‘p’ is presented. This is a  common method 
of measuring cognitive control.
The battery of tests was taken twice by each partici-
pant (for both the experimental and the control group) 
– before and after the  treatment (in 3 months’ time). 
The order in which the  tools are listed corresponds to 
the order in which they were used.
STATISTICAL ANALYSIS
The analyses carried out include intergroup and intra-
group comparisons. The treatment group and the control 
group were compared using the independent (unpaired) 
samples  t-test. Intragroup comparisons concerning 
the treatment group were carried out using the dependent 
(paired) samples t-test. Analyses concerning comparison 
of the treatment group and the control group in terms of 
differences between the first and second measurements 
were performed using a repeated measures analysis of 
variance in the mixed-effects model, considering belong-
ing to the treatment group or to control group as a be-
tween-subjects factor. This type of analysis was conducted 





The mean value of  the  results on the  VAS scale in 
the treatment group was 4.76 with a standard deviation 
of 2.66 and was higher than the mean value in the con-
trol group, which was 0 for all the  subjects. Based on 
the value of the independent samples t-test, it was found 
that the obtained difference was statistically significant, 
t(22) = 8.76, p < 0.001.
TABLE 1. Frequency distribution: drugs used in the treat-
ment of subjects from the treatment group
Anti-inflammatory steroid drugs 1
Anticonvulsants 6
Antimigraine drugs 2
Nonsteroidal anti-inflammatory drugs (NSAIDs) 29
Vitamins and supplements 5
Anti-inflammatory drugs, immunosuppressive drugs 1
Antiallergic drugs 1
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AUDITORY VERBAL LEARNING 
Table 2 shows the mean values of the results of the 
Auditory Verbal Learning Test obtained in the  treat-
ment and the control groups. Two-sided independent 
samples t-test was added to the summary. There were no 
statistically significant differences. However, it is worth 
noting that the  mean values of  the  results obtained in 
the fourth trial and fifth trial were lower in the treatment 
group than in the control group (cf. Figure 1).
ATTENTION AND PERCEPTIVENESS
The analysis of the mean values of the results of the 
Attention and Perceptiveness Test obtained in the treat-
ment and the control groups examined with the two-sided 
independent samples t-test showed no statistically sig-
nificant effects (cf. Table 3).
IMMEDIATE AND WORKING MEMORY
Table 4 below shows the mean values of the results 
of  the  Digit Span Task obtained in the  treatment and 
the control groups. Two-sided independent samples 
t-test was added to the summary. 
In this case, the mean values of the results obtained 
in the treatment group were lower than the mean values 
obtained in the control group (cf. Figure 2).
FIGURE 1. Mean values of the DST results obtained in 
the treatment and the control groups
Treatment Control
















t df pTreatment Control
M SD M SD
1st trial 6.38 1.83 6.95 1.00 –1.27 30.64 0.214
2nd trial 9.48 2.38 10.27 1.39 –1.33 31.87 0.192
3rd trial 11.95 2.19 12.45 1.60 –0.86 42 0.392
4th trial 12.73 1.93 14.14 1.08 –2.98** 33.00 0.005
5th trial 13.55 1.71 14.76 0.44 –3.23** 23.85 0.004
M – mean value, SD – standard deviation, t – test statistic, df – degrees of freedom, p – two-sided statistical significance; **p < 0.01 




t df pTreatment Control
M SD M SD
Number of responses 15.00 2.39 15.77 1.02 –1.39 28.41 0.174
Number of correct responses 8.64 5.46 9.91 2.65 –0.98 30.41 0.333
M – mean value, SD – standard deviation, t – test statistic, df – degrees of freedom, p – two-sided statistical significance
FIGURE 2. Mean values of the DST results obtained in 
the treatment and the control groups
Treatment Control
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30 seconds and 60 seconds, as well as in the semantic cate-
gory 30 seconds. As can be observed, the mean values ob-
tained in the treatment group were lower than the mean 
values obtained in the control group (cf. Figure 3).
EXECUTIVE FUNCTIONS
Table 7 shows the  mean values of  the  results 
of the Wisconsin Card Sorting Test obtained in the treat-
ment and control groups in the 1st and 2nd measurements 
altogether. The  test of  statistical significance of  with-
in-subjects effects conducted in the analysis of variance 
was added to the summary.
The mean values of  the  number of  trials, non-per-
severative errors, trials to complete first category, fail-
ures to maintain set and conceptual level responses were 




t df pTreatment Control
M SD M SD
Result part A 28.79 11.32 25.01 8.26 1.27 42 0.213
Result part  B 39.00 23.71 34.39 17.75 0.72 42 0.473
M – mean value, SD – standard deviation, t – test statistic, df – degrees of freedom, p – two-sided statistical significance; **p < 0.01, ***p < 0.001




t df pTreatment Control
M SD M SD
Lexical category 30 s 12.88 5.64 17.82 4.22 –3.13** 37 0.003
Lexical category 60 s 6.35 3.04 9.82 3.36 –3.33** 37 0.002
Lexical category 90 s 5.24 2.22 6.77 2.62 –1.94 37 0.060
Semantic category 30 s 16.94 4.56 25.64 6.02 –4.95*** 37 0.000
Semantic category 60 s 9.88 3.35 12.59 5.11 –1.89 37 0.066
Semantic category 90 s 6.24 3.36 7.95 2.63 –1.79 37 0.081
M – mean value, SD – standard deviation, t – test statistic, df – degrees of freedom, p – two-sided statistical significance; **p < 0.01, ***p < 0.001




t df pTreatment Control
M SD M SD
Immediate memory 6.05 1.73 7.62 1.28 –3.31** 39 0.002
Working memory 5.86 2.06 7.57 0.68 –3.63** 24.27 0.001
M – mean value, SD – standard deviation, t – test statistic, df – degrees of freedom, p – two-sided statistical significance; **p < 0.01 
CONTINUITY OF ATTENTION AND ALTERNATING 
ATTENTION
The two-sided independent samples t-test did not show 
statistically significant differences between the mean val-
ues of  the  results of  the Trail Making Test obtained in 
the treatment and the control groups (Table 5).
VERBAL FLUENCY
Table shows the mean values of the results of the Ver-
bal Fluency Test obtained in the treatment and the con-
trol groups. Two-sided independent samples t-test was 
added to the summary (Table 6).
Statistically significant intergroup differences were 
observed for the results obtained in the  lexical category 
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TABLE 8. Mean values of the Go/No-go Trial results obtained in the treatment and the control groups in the 1st and 
2nd measurements together with the test of statistical significance
Variable
Group
F df pTreatment Control
M SD M SD
Correct responses 310.55 6.41 308.79 4.27 1.36 1.41 0.250
Number of errors 8.91 6.36 9.36 3.74 0.10 1.41 0.755
M – mean value, SD – standard deviation, F – test statistic, df – degrees of freedom, p – two-sided statistical significance
TABLE 7. Mean values of the WCST results obtained in the treatment and the control groups in the 1st and 2nd me-
asurements together with the test of statistical significance
Variable
Group
F df pTreatment Control
M SD M SD
Categories achieved 2.91 1.14 2.90 1.72 0.01 1.40 0.983
Numer of trials 63.82 0.66 61.80 4.51 4.89* 1.40 0.038
Total number correct 45.45 8.63 40.90 12.13 2.29 1.40 0.138
Total errors 17.43 9.02 21.68 11.76 1.98 1.40 0.167
Perseverative responses 18.23 6.53 25.60 6.80 15.54*** 1.40 0.001
Perseverative errors 7.98 5.79 15.85 8.62 13.69** 1.40 0.001
Non-perseverative errors 10.30 8.25 6.13 2.58 5.25* 1.40 0.027
Trials to complete first category 19.11 9.88 11.10 3.12 18.81*** 1.40 0.001
Failure to maintain set 0.64 0.89 0.05 0.32 8.71** 1.40 0.005
Learning to learn –5792.31 32267.36 0.14 2.86 0.22 1.14 0.647
Conceptual answers 39.84 11.64 31.53 13.49 4.88* 1.40 0.033
M – mean value, SD – standard deviation, F – test statistic, df – degrees of freedom, p – two-sided statistical significance
FIGURE 3. Mean values of the VFT results obtained in 





















higher in the  treatment group, while the  mean values 
of perseverative responses and perseverative errors were 
higher in the control group.
REACTION TIME
Similarly, no statistically significant differences be-
tween the mean values of the results of the Go/No-go Trial 
obtained in treatment and control groups in the 1st and 
2nd measurements altogether were observed. Table 8 in-
cludes the test of statistical significance of between-sub-
jects effects conducted in the analysis of variance, added 
to the summary. 
DISCUSSION
General cognitive functioning of  people who ex-
perience dysfunctions of  the masticatory organ should 
be defined as a  high level, disregarding persistent 
chronic pain experienced. This is indirectly indicated 
by the  analysis of  researched people education, show-
ing that only four people had basic education and all 
the others had higher education or were continuing ed-
ucation at the  university. This is one of  the  main rea-
sons why observing differences in cognitive function-
ing within this particular clinical group is so difficult. 
In other words, probably at least some of the diagnostic 
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tools applied in the study appeared to be too simple for 
the researched people, thus not too sensitive to potential 
cognitive deficiencies. Hence the lack of cognitive defi-
ciencies found in the research group should not provide 
a  conclusion concerning lack of  certain dysfunctions 
in the  population as a  whole. What seems essential is 
the choice of proper diagnostic tools and special atten-
tion to subjective remarks applied by patients. It should 
be taken into consideration that in the  case of  people 
with a good level of cognitive functioning this will of-
ten be the information from the researched subjects that 
constitutes the source of diagnostic knowledge. Unfor-
tunately, in a group of people with such good cognitive 
skills the  smallest deviation from the  standard will be 
subjectively perceived as even more severe. 
Some differences were noted concerning the  course 
of  new information learning processes among peo-
ple experiencing and not experiencing myofascial pain 
in the  course of  temporomandibular disorders. What 
is interesting, however, these differences could be ob-
served during the fourth and fifth repetition of material 
by the researcher – then a distinct decline in the gaining 
of  knowledge by people experiencing pain can be ob-
served. Similarly, in initial stages of auditory and verbal 
learning it is comparable in the case of patients experi-
encing pain as well as those who do not experience it. This 
result may reflect some differences in attention function-
ing, modulating and controlling memory functioning, or 
executive functioning in the scope of ability to plan the 
learning process and/or to motivate to finish the task, 
which decrease with task duration. It is worth noting that 
during this part of the research patients experiencing pain 
often complained about the arduousness of the research 
process and declared an intention to give up the task if it 
lasted longer than five repetitions as planned. Such con-
clusions would be consistent with earlier research devoted 
to patients experiencing chronic pain [47, 48]. However, 
tiredness of the treatment group, appearing with time, 
cannot be ignored, as another, parallel explanation for 
the  differences observed. Chronic pain proper for tem-
poromandibular disorders makes it hard to be effective. 
These results are coherent with information concerning 
patients with fibromyalgia in whom an essential mediat-
ing role of effort put into the quality of cognitive tasks was 
observed, especially for memory tasks [49]. 
Analysis of  results in the  scope of  continuity and 
shifting attention measured with the Point Matching Test 
did not prove any differences in functioning of the two 
groups observed in the study. The Point Matching Test 
is a tool in which people are asked to combine numbers 
with the use of straight lines in growing order as fast as 
possible, whereas on the second sheet they must be com-
bined by turns with letters in alphabetical order. This 
tool, apart from efficient attentive functioning,  requires 
efficient executive functions, especially planning ability 
and cognitive flexibility [50-53]. It seems, however, that 
these are in fact more complex cognitive functions, diffi-
cult to start in the case of a suggested task that other au-
thors already paid attention to [53]. This result is similar 
to those obtained with the help of this tool (or similar 
tools) in the case of different kinds of chronic pain. Both 
during comparison to standard data [54] and compari-
son to healthy people [55] – no essential results have been 
obtained. What seems also significant is that this result is 
highly dependent on intellectual functioning, age or ed-
ucation [56, 57]. Simultaneously, research taking into ac-
count other kinds of measurements focusing on descrip-
tion of  attentive and executive functioning of  patients 
with temporomandibular disorders, allowed one to dis-
tinguish between people experiencing chronic pain and 
the others [58, 59].
Similarly, when it comes to other factors  of at-
tentive and perceptive functioning (the speed of 
perception, perception and attention unreliability 
as measured with the Attention and Perceptiveness 
Test) – the reseach did not confirm any differences be-
tween people experiencing myofascial pain and peo-
ple not experiencing such pain. This result is different 
as compared to those achieved by e.g. patients with 
fibromyalgia [60]. As in the case of the previous tool, it 
can be assumed that the  tool appeared to be too sim-
ple for this particular research group. Alternatively, it 
may be the case that the Attention and Perception Test 
as well as the Point Matching Test trials were too short. 
If extended by a few minutes, the procedure could pos-
sibly allow one to eventually observe some differences 
in attention and perception functioning of patients ex-
periencing pain and those not presenting these kinds 
of symptoms. Some other results achieved in the same 
research may provide arguments for this second 
explanation. 
At the same time, people experiencing pain achieved 
worse results for short term memory, as well as audi-
tory and verbal operational memory, than people not 
feeling pain. This result is coherent with research de-
voted to chronic pain with various etiology  [61-63]. 
Attention must be paid to the fact that performance in 
trials measuring short-term memory as well as opera-
tional memory requires efficient attention mechanisms. 
Therefore, it can be indirectly concluded that in the case 
of  the researched group it turned out that mental pro-
cessing of material was more difficult than carrying out 
operations on visual material. At the  same time, lack 
of  a  visual stimulus leading through the  task result-
ed in achieving worse quality of  the  task performed. 
It must be underlined at this point that people expe-
riencing pain showed memory capacity (in the  scope 
of  direct capacity of  auditory and verbal memory) 
matching Miller’s number standards (7 ± 2 elements), 
which was reflected in both the digit matching test and 
the learning test.
Difficulty in the  scope of  cognitive functioning 
of  people experiencing myofascial pain in temporo-
manidbular disorders, as compared to people who do 
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not experience this kind of pain, are also visible in word 
fluency trials. These are the  tasks aiming at updating 
semantic knowledge resources (association aspect), 
the  initiation process and activity control (including 
inhibiting unnecessary reactions), operational memo-
ry and attention, and cognitive flexibility enabling the 
initiation of  various strategies (imagination, sound) 
(executive aspect)  [64-66]. In  the  research differences 
in performance of  tasks by people experiencing and 
not experiencing pain were visible in both cases during 
the first 30 seconds of the task – regardless of whether 
the  task engaged lexical or semantic fluency. This re-
sult seems to confirm that both types of tasks are based 
on similar cognitive (semantic and executive) as well 
as neurophysiological mechanisms, including the  role 
of  the  prefrontal cortex and anterior cingulate cortex 
of  both hemispheres  [69-74]. Simultaneously it sug-
gests the  decline in intentional attention (connected 
with conscious, intended, active orientation of  cogni-
tive functions to a  given stimulus) in the  case of  peo-
ple experiencing chronic pain in the  course of  tem-
poromandibular disorders. In  cognitive psychology 
there is a  notion of  ‘cognitive warming up’ which can 
be defined by mobilization, a  state of  increased readi-
ness of cognitive processes to fulfill their function [75]. 
It seems that this notion can be applied to research re-
sults obtained, defining the research group as one repre-
senting essentially lower ability to start cognitive warm-
ing-up processes. 
Lexical fluency in the 60th second of research shows 
difference between people experiencing pain and not 
experiencing pain, however there was no difference in 
semantic fluency. It can be therefore stated that myofas-
cial pain seems to essentially disorganize word lexical 
fluency more than in the semantic one. This means that 
people experiencing this kind of  pain have, in general, 
better ability to update words in a given semantic cate-
gory than to update words starting with a given letter. It 
may result from the fact that semantic processing engages 
cognition more and influences the quality of the task per-
formed. The assumption that stronger focusing on a task, 
resulting from the  initiation of  processing information 
on a deeper level, essentially decreases the overwhelming 
impact of the pain factor on cognitive functions, may be 
very hypothetical. This result can suggest predominance 
of  the aspect of meaning in the  information processing 
for people experiencing myofascial pain. As semantic 
fluency requires starting of  recollection processes, sight 
and imagination processes, the  result obtained can also 
suggest that people experiencing this kind of pain remain 
concentrated on these kinds of aspects of everyday expe-
rience. Quality analysis of  words generated by patients 
with clear reduction of pain could turn out to be inter-
esting, delivering interesting results about mechanisms 
of information processing in this group of patients [76]. 
In the Go/No-go clinical trial, constituting measure-
ment of reaction speed as well as an ability to stop it, no 
vital differences were discovered, similarly to research 
devoted to fibromyalgia  [77]. However, it must be not-
ed that in research quoted in spite of  differences found 
during research lowered activity was observed in those 
parts of  the  brain responsible for inhibiting reactions 
(frontal lower gyrus). It can be, therefore, assumed that 
although the  suggested diagnostic procedure was not 
difficult enough to observe an  explicit effect, in other, 
more cognitively engaging tasks such differences could 
appear.
The research also proved some differences in func-
tioning of patients experiencing pain and those who do 
not experience it in the  scope of  executive functions. 
This result is even more interesting as only a  few stud-
ies using the Wisconsin Card Sorting Test have proved 
so far any essential effects differentiating people experi-
encing chronic pain from the others [78, 79]. People ex-
periencing pain featured a greater number of trials that 
were necessary to solve a  problem task, longer process 
of  initially looking for a  concept and poorer ability to 
maintain the  same attitude, that is completing the  task 
without making a mistake (ie. resistence to frustration). 
These abilities surely refer to everyday existence of  pa-
tients but also to a  simple treatment process – among 
others, understanding own health situation and fulfilling 
the  doctor’s recommendations during the  whole treat-
ment process. What is important, however, is that not all 
the measured cognitive functions weakened in the case 
of  patients experiencing pain. Better insight into the 
strategy of solving the task correctly is an example of exe- 
cutive functions that turned out to be more effective for 
pain feeling patients. It can be acknowledged as an effect 
of  this not too numerous clinical trial or explained by 
noting that pain encourage people to look for its sense, 
meaning, aim. 
CONCLUSIONS
Summing up, it must be observed that the  neu-
ro-cognitive profile of  specific functions prone to 
the  impact of  myofascial pain in temporomandibu-
lar disorders seems to include executive functions, at-
tention, operation memory, thus cognitive functions, 
with the  essential role of the  prefrontal cortex, espe-
cially its dorsal and side part. This brain area is im-
portant in higher forms of  behavior, such as action 
planning and programming, performance control or 
its regulation. It seems, therefore, that it is the central 
nervous system that becomes one of the most encum-
bered by chronic myofascial pain in temporomandib-
ular disorders. The  obtained results seem to deliver 
a  range of  practical implications concerning the  way 
patients are presented with information about diagnosis 
or treatment planning process. The results suggest that 
it is essential to lower the  level of pain felt by patients 
fast, so that they can better and more actively partic-
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ipate in the  therapeutic process. Until considerable 
reduction of pain has been achieved, it is essential that 
the treating person pays attention to the way in which 
information is transferred to the  patient and its con-
text. Systematic work ought to be focused on increasing 
the level of resistence to both frustration and therapeutic 
failure,  which seem essential in the context of the high 
rate of disorders recurrence. 
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